WAVE Life Sciences (NASDAQ: WVE - Get Free Report) and Tonix Pharmaceuticals (NASDAQ: TNXP - Get Fre

On October 1, 2026, Tonix Pharmaceuticals Holding Corp. (the "Company") received a notice (t

Agreement for the treatment of fibromyalgia in adults that is effective immediately, adding approxim

Tonix Pharmaceuticals (NASDAQ:TNXP) reported quarterly losses of $(2.44) per share which beat the an

Alignment with FDA on key elements of the study design support planned start of the Phase 2 study in

Data show clade IIb from 2022 outbreak is 100 to 100,000-fold less virulent than clade IIa from 2003

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) ("Tonix" or "the Company"), a full

Top Wall Street analysts changed outlook on top names. See all changes incl. upgrades, downgrades &a

Wall Street analysts change outlook on top names, with downgrades and initiations. See analyst ratin

Analysts changed outlook on top names, including Intel and Arrow Financial. See ratings page. TNXP s

Raymond James analyst Tiago Fauth initiates coverage on Tonix Pharmaceuticals (NASDAQ:TNXP) with

Tonix Pharmaceuticals Holding shares are trading higher Monday after securing second commercial paye

Agreement with second leading group purchasing organization (GPO), effective June 1, 2026, provides

Real-world analysis of three years of closed claims data from Symphony Health, focused on the third

Phase 1 data support TNX-1500 as a potentially first-in-class, best-in-class, third-generation anti-

Real-world analysis of three years of closed claims data from Symphony Health focused on the third y

Tonix Pharmaceuticals (NASDAQ:TNXP) reported quarterly losses of $(2.93) per share which missed the

Tonix Pharmaceuticals Holding shares are trading higher Wednesday after announcing commercial payer

Agreement with leading group purchasing organization (GPO) provides access to approximately 35 milli

TD Cowen analyst Stacy Ku initiates coverage on Tonix Pharmaceuticals (NASDAQ:TNXP) with a Buy ra

Company on track to initiate a randomized, double-blind, placebo-controlled, adaptive Phase 2 field

TNX-1700 (TFF2-albumin fusion protein) reversed aging-associated gastric inflammation and significan

The publication reports findings from a single-center, randomized, open-label, multiple-dose, parall

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) ("Tonix" or the "Company"), a full

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) shares are trading lower Monday morning, hitting a

Intranasal oxytocin blocks the release of calcitonin gene-related peptide (CGRP) in animal models an

Monday, March 30: Phase 1 data on TNX-4800 (long-acting anti-Borrelia OspA human monoclonal antibody

Tonix Pharmaceuticals beats expectations, and Tonmya prescriptions grow, with over 4,200 prescriptio